bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Figure 5 from Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples
Authors: Veldman-Jones Margaret H. , Brant Roz , Rooney Claire , Geh Catherine , Emery Hollie , Harbron Chris G. , Wappett Mark , Sharpe Alan , Dymond Michael , Barrett J. Carl , Harrington Elizabeth A. , Marshall Gayle
Published: April 2023

Supplemental Figure 5A: Correlation scatter plot of normalised log2 values illustrating stability of a CodeSet after expiry date. A CodeSet consisting of 30 genes including 4 housekeeping genes was tested with a set of 6 identical samples (5 Fresh DLBCL tissues and 1 DLBCL cell line HBL-1) over an extended time-period of 2.5 years; the second test was performed 1.5 years after the CodeSet expiry date. Supplemental Figure 5B: Correlation scatter plot of mean normalised log2 counts of triplicate UHR samples tested with a CodeSet consisting of 463 genes including 18 housekeeping genes subjected to 4 freeze/thaw cycles.
Supplementary Table 3 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
Authors: Simó-Riudalbas Laia , Pérez-Salvia Montserrat , Setien Fernando , Villanueva Alberto , Moutinho Catia , Martínez-Cardús Anna , Moran Sebastian , Berdasco Maria , Gomez Antonio , Vidal Enrique , Soler Marta , Heyn Holger , Vaquero Alejandro , de la Torre Carolina , Barceló-Batllori Silvia , Vidal August , Roz Luca , Pastorino Ugo , Szakszon Katalin , Borck Guntram , Moura Conceição S. , Carneiro Fátima , Zondervan Ilse , Savola Suvi , Iwakawa Reika , Kohno Takashi , Yokota Jun , Esteller Manel
Published: April 2023

Supplementary Table 3. The twenty-eight HDAC inhibitors used in the study and their specificity
Supplementary information from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
Authors: Bertrand Florie , Rochotte Julia , Colacios Céline , Montfort Anne , Tilkin-Mariamé Anne-Françoise , Touriol Christian , Rochaix Philippe , Lajoie-Mazenc Isabelle , Andrieu-Abadie Nathalie , Levade Thierry , Benoist Hervé , Ségui Bruno
Published: April 2023

Supplementary information. This file contains supplementary materials and methods, and legends to supplementary figures.
Supplementary Table 1 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
Authors: Simó-Riudalbas Laia , Pérez-Salvia Montserrat , Setien Fernando , Villanueva Alberto , Moutinho Catia , Martínez-Cardús Anna , Moran Sebastian , Berdasco Maria , Gomez Antonio , Vidal Enrique , Soler Marta , Heyn Holger , Vaquero Alejandro , de la Torre Carolina , Barceló-Batllori Silvia , Vidal August , Roz Luca , Pastorino Ugo , Szakszon Katalin , Borck Guntram , Moura Conceição S. , Carneiro Fátima , Zondervan Ilse , Savola Suvi , Iwakawa Reika , Kohno Takashi , Yokota Jun , Esteller Manel
Published: April 2023

Supplementary Table 1. List of antibodies and primer sets used in the study.
Supplementary Figure 7 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
Authors: Simó-Riudalbas Laia , Pérez-Salvia Montserrat , Setien Fernando , Villanueva Alberto , Moutinho Catia , Martínez-Cardús Anna , Moran Sebastian , Berdasco Maria , Gomez Antonio , Vidal Enrique , Soler Marta , Heyn Holger , Vaquero Alejandro , de la Torre Carolina , Barceló-Batllori Silvia , Vidal August , Roz Luca , Pastorino Ugo , Szakszon Katalin , Borck Guntram , Moura Conceição S. , Carneiro Fátima , Zondervan Ilse , Savola Suvi , Iwakawa Reika , Kohno Takashi , Yokota Jun , Esteller Manel
Published: April 2023

Supplementary Figure 7. Effect of twenty-eight histone deacetylase inhibitors and two classical drugs in SCLC chemotherapy, such as cisplatin and etoposide, in the IC50 values of KAT6B shRNA-transfected vs scramble shRNA-transfected NCI-N417 cells.
Supplementary Figure 4 from KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer
Authors: Simó-Riudalbas Laia , Pérez-Salvia Montserrat , Setien Fernando , Villanueva Alberto , Moutinho Catia , Martínez-Cardús Anna , Moran Sebastian , Berdasco Maria , Gomez Antonio , Vidal Enrique , Soler Marta , Heyn Holger , Vaquero Alejandro , de la Torre Carolina , Barceló-Batllori Silvia , Vidal August , Roz Luca , Pastorino Ugo , Szakszon Katalin , Borck Guntram , Moura Conceição S. , Carneiro Fátima , Zondervan Ilse , Savola Suvi , Iwakawa Reika , Kohno Takashi , Yokota Jun , Esteller Manel
Published: April 2023

Supplementary Figure 4. Effect of KAT6B shRNA-mediated depletion in the growth rate according to the XTT assay
Supplemental Tables S1-S4 from Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites
Authors: Wang Qilong , Ren Yi , Mu Jingyao , Egilmez Nejat K. , Zhuang Xiaoyin , Deng Zhongbin , Zhang Lifeng , Yan Jun , Miller Donald , Zhang Huang-Ge
Published: April 2023

Supplemental Tables S1-S4. Characteristics of 20 colon cancer patients (S1); Characteristics of 21 breast cancer patients (S2); IHC scores of chemokines (CXCL1, CXCL10, CCL2 and CCL5) in human colon cancer tissues (S3); IHC scores of chemokines (CXCL1, CXCL10, CCL2 and CCL5) in human breast cancer tissues (S4).
Supplementary Figures S1-S9 from Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death
Authors: Lee Eric A. , Angka Leonard , Rota Sarah-Grace , Hanlon Thomas , Mitchell Andrew , Hurren Rose , Wang Xiao Ming , Gronda Marcela , Boyaci Ezel , Bojko Barbara , Minden Mark , Sriskanthadevan Shrivani , Datti Alessandro , Wrana Jeffery L. , Edginton Andrea , Pawliszyn Janusz , Joseph Jamie W. , Quadrilatero Joe , Schimmer Aaron D. , Spagnuolo Paul A.
Published: April 2023

Supplementary Figures S1-S9. Avocatin B is the most active avocado lipid analogue (S1); Kinetics of avocatin B-induced death (S2); Cell cycle analysis of avocatin B treated TEX cells (S3); Avocatin B increases DCFH-DA and DHE (S4); Avocatin B's activity is neutralized by co-incubation with PEG-SOD (S5); Jurkat T cells cultured in ethidium bromide medium have reduced mitochondria with decreased function (S6); Avocatin B is absent in mitochondria and cytosolic fractions of vehicle control treated TEX cells (S7); Avocatin B calibration curves and estimated concentraiton in cytosolic and mitochondrial fractions (S8); Avocatin B decreases levels of NADH and NADPH and increases ROS in OCI-AML2 cells (S9).
Supplemental Figure 2 from Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin Binding
Authors: Goldstein Michael , Kastan Michael B.
Published: April 2023

Figure S2. Efficiency of the siRNA-mediated knock-down of Nbs1, Brca1 and Rap80 was assessed by immunoblot
Supplementary Methods and References from Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma
Authors: Soroceanu Liliana , Matlaf Lisa , Khan Sabeena , Akhavan Armin , Singer Eric , Bezrookove Vladimir , Decker Stacy , Ghanny Saleena , Hadaczek Piotr , Bengtsson Henrik , Ohlfest John , Luciani-Torres Maria-Gloria , Harkins Lualhati , Perry Arie , Guo Hong , Soteropoulos Patricia , Cobbs Charles S.
Published: April 2023

Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplementary Table S5 from A Molecular Portrait of High-Grade Ductal Carcinoma In Situ
Authors: Abba Martin C. , Gong Ting , Lu Yue , Lee Jaeho , Zhong Yi , Lacunza Ezequiel , Butti Matias , Takata Yoko , Gaddis Sally , Shen Jianjun , Estecio Marcos R. , Sahin Aysegul A. , Aldaz C. Marcelo
Published: April 2023

Supplementary Table S5: Differentially methylated CpGi regions among normal and DCIS samples and their correlation with gene expression.
Supplementary Table S2 from A Molecular Portrait of High-Grade Ductal Carcinoma In Situ
Authors: Abba Martin C. , Gong Ting , Lu Yue , Lee Jaeho , Zhong Yi , Lacunza Ezequiel , Butti Matias , Takata Yoko , Gaddis Sally , Shen Jianjun , Estecio Marcos R. , Sahin Aysegul A. , Aldaz C. Marcelo
Published: April 2023

Supplementary Table S2: List of mutated genes, Indels and Copy number variations detected in DCIS samples.
Supplemental Figure Legends from KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine
Authors: Stewart Michelle L. , Tamayo Pablo , Wilson Andrew J. , Wang Stephanie , Chang Yun Min , Kim Jong W. , Khabele Dineo , Shamji Alykhan F. , Schreiber Stuart L.
Published: April 2023

Supplemental Figure Legends
Supplemental Figure S5 from CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling
Authors: Moutal Aubin , Honnorat Jérôme , Massoma Patrick , Désormeaux Pauline , Bertrand Caroline , Malleval Céline , Watrin Chantal , Chounlamountri Naura , Mayeur Marie-Eve , Besançon Roger , Naudet Nicolas , Magadoux Léa , Khanna Rajesh , Ducray François , Meyronet David , Thomasset Nicole
Published: April 2023

Notch1 is activated in the GL15 GBM cell line. (A): Notch staining in non-treated cells. (B): Notch1 staining in EDTA-treated cells mimicking Notch activation and nuclear translocation. (C): Notch1 staining in DMSO-treated cells. (D): Notch1 staining after DAPT (inhibitor of Notch nuclear translocation) treatment. Scale bar=5µm.
Supplemental Figure S3 from CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling
Authors: Moutal Aubin , Honnorat Jérôme , Massoma Patrick , Désormeaux Pauline , Bertrand Caroline , Malleval Céline , Watrin Chantal , Chounlamountri Naura , Mayeur Marie-Eve , Besançon Roger , Naudet Nicolas , Magadoux Léa , Khanna Rajesh , Ducray François , Meyronet David , Thomasset Nicole
Published: April 2023

CRMP5 depletion with CRMP5 siRNA2, inhibits proliferation. (A): CRMP5 expression using western blot after CRMP5 siRNA2 transfection. (B): Proliferation analysis in A172 cells transfected with CRMP5-siRNA2 or control-siRNA (p<0.001; Mann-Whitney test) and (C): Cell cycle analysis using DNA content by flow cytometry in GL15 cells transfected with CRMP5-siRNAor control-siRNA (D): Growth rate trial of Xenograft CRMP5 positive GBM_SC1 and CRMP5 negative GBM_SC2 after flank injection in nude mice.
Supplementary Figure 1 from Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway
Authors: von Witzleben Adrian , Goerttler Lukas T. , Marienfeld Ralf , Barth Holger , Lechel André , Mellert Kevin , Böhm Michael , Kornmann Marko , Mayer-Steinacker Regine , von Baer Alexandra , Schultheiss Markus , Flanagan Adrienne M. , Möller Peter , Brüderlein Silke , Barth Thomas F.E.
Published: April 2023

Overview ideogram of CGH data of all chordoma cell lines. Every cell line corresponds to one color. Lines on the left side are losses, and on the right side are gains of chromosomal material. Arrows mark the CDK6 region on 7q and p16 region on 9p.
Data Supplement from Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway
Authors: von Witzleben Adrian , Goerttler Lukas T. , Marienfeld Ralf , Barth Holger , Lechel André , Mellert Kevin , Böhm Michael , Kornmann Marko , Mayer-Steinacker Regine , von Baer Alexandra , Schultheiss Markus , Flanagan Adrienne M. , Möller Peter , Brüderlein Silke , Barth Thomas F.E.
Published: April 2023

Data Supplement from Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway
Supplementary Table 3 from Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures
Authors: Stone Jennifer , Thompson Deborah J. , dos Santos Silva Isabel , Scott Christopher , Tamimi Rulla M. , Lindstrom Sara , Kraft Peter , Hazra Aditi , Li Jingmei , Eriksson Louise , Czene Kamila , Hall Per , Jensen Matt , Cunningham Julie , Olson Janet E. , Purrington Kristen , Couch Fergus J. , Brown Judith , Leyland Jean , Warren Ruth M.L. , Luben Robert N. , Khaw Kay-Tee , Smith Paula , Wareham Nicholas J. , Jud Sebastian M. , Heusinger Katharina , Beckmann Matthias W. , Douglas Julie A. , Shah Kaanan P. , Chan Heang-Ping , Helvie Mark A. , Le Marchand Loic , Kolonel Laurence N. , Woolcott Christy , Maskarinec Gertraud , Haiman Christopher , Giles Graham G. , Baglietto Laura , Krishnan Kavitha , Southey Melissa C. , Apicella Carmel , Andrulis Irene L. , Knight Julia A. , Ursin Giske , Alnaes Grethe I. Grenaker , Kristensen Vessela N. , Borresen-Dale Anne-Lise , Gram Inger Torhild , Bolla Manjeet K. , Wang Qin , Michailidou Kyriaki , Dennis Joe , Simard Jacques , Pharoah Paul , Dunning Alison M. , Easton Douglas F. , Fasching Peter A. , Pankratz V. Shane , Hopper John L. , Vachon Celine M.
Published: April 2023

Supplementary Table 3. Associations (95% Confidence Interval (CI) in brackets) between breast cancer susceptibility variants and the mammographic measures with adjustment for case-control status
Supplementary Table 1 from STAT3-Mediated Autophagy Dependence Identifies Subtypes of Breast Cancer Where Autophagy Inhibition Can Be Efficacious
Authors: Maycotte Paola , Gearheart Christy M. , Barnard Rebecca , Aryal Suraj , Mulcahy Levy Jean M. , Fosmire Susan P. , Hansen Ryan J. , Morgan Michael J. , Porter Christopher C. , Gustafson Daniel L. , Thorburn Andrew
Published: April 2023

PDF file - 117K, Supplementary table 1. Changes in shRNAs included in the autophagy library per cell line. Cells were transduced with a shRNA library containing autophagy-focused shRNAs. After transduction, the first sample (Post-transduction, PT) was collected. Growth sample (G) was collected after 15 days in culture. Both samples were done in quintuplicate. Table shows comparison of PT versus G samples. shRNAs were considered to be up (Sign Tag = U), or down-regulated (Sign Tag = D) in the growth sample when ANOVA p-value < 0.05 and fold change absolute value > 2.
Supplementary Figure S5 from Rho Kinase Inhibitors Block Melanoma Cell Migration and Inhibit Metastasis
Authors: Sadok Amine , McCarthy Afshan , Caldwell John , Collins Ian , Garrett Michelle D. , Yeo Maggie , Hooper Steven , Sahai Erik , Kuemper Sandra , Mardakheh Faraz K. , Marshall Christopher J.
Published: April 2023

Supplementary Figure S5. Images show H&E and S100 stainings of lungs invaded with either vehicle- or drug-treated cells 24 days after the injection into the tail vein of athymic mice.
Supplemental Table 1 from The Cyclic AMP Pathway Is a Sex-Specific Modifier of Glioma Risk in Type I Neurofibromatosis Patients
Authors: Warrington Nicole M. , Sun Tao , Luo Jingqin , McKinstry Robert C. , Parkin Patricia C. , Ganzhorn Sara , Spoljaric Debra , Albers Anne C. , Merkelson Amanda , Stewart Douglas R. , Stevenson David A. , Viskochil David , Druley Todd E. , Forys Jason T. , Reilly Karlyne M. , Fisher Michael J. , Tabori Uri , Allen Jeffrey C. , Schiffman Joshua D. , Gutmann David H. , Rubin Joshua B.
Published: April 2023

Supplemental Table 1: Specimen Characteristics.
Supplementary Table S2 from B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
Authors: Herr Ricarda , Köhler Martin , Andrlová Hana , Weinberg Florian , Möller Yvonne , Halbach Sebastian , Lutz Lisa , Mastroianni Justin , Klose Martin , Bittermann Nicola , Kowar Silke , Zeiser Robert , Olayioye Monilola A. , Lassmann Silke , Busch Hauke , Boerries Melanie , Brummer Tilman
Published: April 2023

Supplementary Table S2. Excel-file with all differentially expressed genes.
Supplementary Figures S1-S8 from B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
Authors: Herr Ricarda , Köhler Martin , Andrlová Hana , Weinberg Florian , Möller Yvonne , Halbach Sebastian , Lutz Lisa , Mastroianni Justin , Klose Martin , Bittermann Nicola , Kowar Silke , Zeiser Robert , Olayioye Monilola A. , Lassmann Silke , Busch Hauke , Boerries Melanie , Brummer Tilman
Published: April 2023

Supplementary Figures S1-S8. Effects of oncogenic B-Raf signaling on the phenotype of HT29 and Caco2-tet cells in conventional tissue culture (S1); Analysis of the loss of oncogenic B-Raf signaling on the phenotype of HT29 and Colo-205 cells (S2); Effects of B-RafV600E knockdown on Colo-205 cells (S3); Additional information on the transcriptome analysis of HT29 and Colo-205 spheroids, including further validation at the protein level (S4); Additional data supporting the (inverse) relationship between B-RafV600E signaling and the expression of Cdx-2, KIAA1199 and Claudins in HT29 and Colo-205 cells (S5); Additional data addressing the effects of B-RafV600E signaling on transcripts associated with invasion and stemness, on xenograft growth and tight junction proteins (S6); Supplementary data showing the single-channel images corresponding to Fig. 2C and 3D, respectively (S7); Inhibition of B-RafV600E modulates transcripts associated with intestinal differentiation (S8).
Supplementary Results and Tables 1 - 4 from Twist1 Is a Key Regulator of Cancer-Associated Fibroblasts
Authors: Lee Keun-Woo , Yeo So-Young , Sung Chang Ohk , Kim Seok-Hyung
Published: April 2023

Supplementary Table 1. CXCL12 protein expression in epithelial cells of normal gastric epithelium, dysplasia (adenoma), and adenocarcinoma. Supplementary Table 2. The associations between CXCL12 expression in cancer cells and clinicopathologic variables. Supplementary Table 3. CXCL12 protein expression in stromal fibroblasts of normal gastric epithelium, dysplasia (adenoma), and adenocarcinoma. Supplementary Table 4. Relations between of CXCL12 expression in fibroblasts and clinicopathologic features in gastric adenocarcinoma.
Supplementary Table. S5 from Development of Lung Adenocarcinomas with Exclusive Dependence on Oncogene Fusions
Authors: Saito Motonobu , Shimada Yoko , Shiraishi Kouya , Sakamoto Hiromi , Tsuta Koji , Totsuka Hirohiko , Chiku Suenori , Ichikawa Hitoshi , Kato Mamoru , Watanabe Shun-ichi , Yoshida Teruhiko , Yokota Jun , Kohno Takashi
Published: April 2023

Supplementary Table. S5. Mutation frequency of the 127 SMGs for 20 cellular processes in the study and TCGA cohort
Supplemental Figure S4 from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition
Authors: Xiao Lin , Kim Dae Joong , Davis Clayton L. , McCann James V. , Dunleavey James M. , Vanderlinden Alissa K. , Xu Nuo , Pattenden Samantha G. , Frye Stephen V. , Xu Xia , Onaitis Mark , Monaghan-Benson Elizabeth , Burridge Keith , Dudley Andrew C.
Published: April 2023

Supplemental Figure S4. bFGF reverses TGFβ2-induced morphological changes and target gene expression in SMA+ TEC.
Supplemental Figure S3 from Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition
Authors: Xiao Lin , Kim Dae Joong , Davis Clayton L. , McCann James V. , Dunleavey James M. , Vanderlinden Alissa K. , Xu Nuo , Pattenden Samantha G. , Frye Stephen V. , Xu Xia , Onaitis Mark , Monaghan-Benson Elizabeth , Burridge Keith , Dudley Andrew C.
Published: April 2023

Supplemental Figure S3. Representative tile immunofluorescent images of mammary tumors from ZsGreenCdh5-Cre mice.
Supplementary Table 3 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells
Authors: Koch Adam T. , Love-Homan Laurie , Espinosa-Cotton Madelyn , Stanam Aditya , Simons Andrean L.
Published: April 2023

Cal-27 Network list.
Supplementary Methods and References from Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling
Authors: Zhong Shuangshuang , Yin Huijing , Liao Yueling , Yao Feng , Li Qi , Zhang Jie , Jiao Huike , Zhao Yongxu , Xu Dongliang , Liu Shuli , Song Hongyong , Gao Yong , Liu Jingyi , Ma Lina , Pang Zhi , Yang Ruixu , Ding Chengyi , Sun Beibei , Lin Xiaofeng , Ye Xiaofeng , Guo Wenzheng , Han Baohui , Zhou Binhua P. , Chin Y. Eugene , Deng Jiong
Published: April 2023

Supplementary Methods and References. Description of additional methods and procedures used in the study. Also includes Supplementary References.
Supplementary Figure 3 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells
Authors: Koch Adam T. , Love-Homan Laurie , Espinosa-Cotton Madelyn , Stanam Aditya , Simons Andrean L.
Published: April 2023

Human HNSCC tumors display elevated expression of IL-1 pathway components.
Figure S5 from Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells
Authors: Peyvandi Sanam , Buart Stéphanie , Samah Boubekeur , Vétizou Marie , Zhang Yanyan , Durrieu Ludovic , Polrot Mélanie , Chouaib Salem , Benihoud Karim , Louache Fawzia , Karray Saoussen
Published: April 2023

Figure S5. Thioglycollate-induced inflammation.
Figure S2 from Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells
Authors: Peyvandi Sanam , Buart Stéphanie , Samah Boubekeur , Vétizou Marie , Zhang Yanyan , Durrieu Ludovic , Polrot Mélanie , Chouaib Salem , Benihoud Karim , Louache Fawzia , Karray Saoussen
Published: April 2023

Figure S2. Reduced proportion of CD11b+Gr-1+ MDSCs cells in Fasl-/- mice bearing B16 melanoma and leukemic cells.
Supplementary Figure S3 from Long Noncoding RNA HULC Modulates Abnormal Lipid Metabolism in Hepatoma Cells through an miR-9–Mediated RXRA Signaling Pathway
Authors: Cui Ming , Xiao Zelin , Wang Yue , Zheng Minying , Song Tianqiang , Cai Xiaoli , Sun Baodi , Ye Lihong , Zhang Xiaodong
Published: April 2023

Supplementary Figure S3. MiR-9 inhibits the expression of PPARA by targeting the 3ï‚¢UTR of PPARA, Related to Figure 3.
Supplementary Figure S3 from Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival
Authors: Langenkamp Elise , Zhang Lei , Lugano Roberta , Huang Hua , Elhassan Tamador Elsir Abu , Georganaki Maria , Bazzar Wesam , Lööf Johan , Trendelenburg George , Essand Magnus , Pontén Fredrik , Smits Anja , Dimberg Anna
Published: April 2023

Effect of CD93-deficiency in T241 and GL261 necrosis, hypoxia, and apoptosis.
Figure S7 from Cell Cycle–Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells
Authors: Kothari Anisha , Hittelman Walter N. , Chambers Timothy C.
Published: April 2023

Supplementary Figure 7
Figure S3 from Cell Cycle–Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells
Authors: Kothari Anisha , Hittelman Walter N. , Chambers Timothy C.
Published: April 2023

Supplementary Figure 3
Supplemental Table S5 from The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
Authors: Harms Paul William , Vats Pankaj , Verhaegen Monique Elise , Robinson Dan R. , Wu Yi-Mi , Dhanasekaran Saravana Mohan , Palanisamy Nallasivam , Siddiqui Javed , Cao Xuhong , Su Fengyun , Wang Rui , Xiao Hong , Kunju Lakshmi P. , Mehra Rohit , Tomlins Scott A. , Fullen Douglas Randall , Bichakjian Christopher Keram , Johnson Timothy M. , Dlugosz Andrzej Antoni , Chinnaiyan Arul M.
Published: April 2023

Supplemental Table S5. Statistical summary for exonic mutations in Merkel cell carcinoma cases
Supplementary Fig. S6 from Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer
Authors: Yoo Byunghee , Kavishwar Amol , Ross Alana , Wang Ping , Tabassum Doris P. , Polyak Kornelia , Barteneva Natalia , Petkova Victoria , Pantazopoulos Pamela , Tena Aseda , Moore Anna , Medarova Zdravka
Published: April 2023

Supplementary Fig. S6. Gross anatomical features of mice treated with MN-anti-miR10b and doxorubicin.
Supplemental Table S4 from The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
Authors: Harms Paul William , Vats Pankaj , Verhaegen Monique Elise , Robinson Dan R. , Wu Yi-Mi , Dhanasekaran Saravana Mohan , Palanisamy Nallasivam , Siddiqui Javed , Cao Xuhong , Su Fengyun , Wang Rui , Xiao Hong , Kunju Lakshmi P. , Mehra Rohit , Tomlins Scott A. , Fullen Douglas Randall , Bichakjian Christopher Keram , Johnson Timothy M. , Dlugosz Andrzej Antoni , Chinnaiyan Arul M.
Published: April 2023

Supplemental Table S4. Copy number variations detected by exome sequencing in index cases
Supplemental Methods and Figure Legends from A Urokinase Receptor–Bim Signaling Axis Emerges during EGFR Inhibitor Resistance in Mutant EGFR Glioblastoma
Authors: Wykosky Jill , Hu Jingjing , Gomez German G. , Taylor Tiffany , Villa Genaro R. , Pizzo Donald , VandenBerg Scott R. , Thorne Amy Haseley , Chen Clark C. , Mischel Paul S. , Gonias Steven L. , Cavenee Webster K. , Furnari Frank B.
Published: April 2023

Supplemental Methods and Figure Legends
Supplemental Figure S5 from A Urokinase Receptor–Bim Signaling Axis Emerges during EGFR Inhibitor Resistance in Mutant EGFR Glioblastoma
Authors: Wykosky Jill , Hu Jingjing , Gomez German G. , Taylor Tiffany , Villa Genaro R. , Pizzo Donald , VandenBerg Scott R. , Thorne Amy Haseley , Chen Clark C. , Mischel Paul S. , Gonias Steven L. , Cavenee Webster K. , Furnari Frank B.
Published: April 2023

Supplemental Figure S5. MEK inhibition restores sensitivity to EGFR TKi
Supplementary Figure S4 from PIK3CAH1047R Accelerates and Enhances KRASG12D-Driven Lung Tumorigenesis
Authors: Green Shon , Trejo Christy L. , McMahon Martin
Published: April 2023

Pharmacodynamic analysis of the inhibitory effects of BYL719 on pAKT in mice bearing KRASG12D/PIK3CAH1047R-driven lung tumors.
Supplementary Table 1 from Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis
Authors: Sorokin Alexey V. , Nair Binoj C. , Wei Yongkun , Aziz Kathryn E. , Evdokimova Valentina , Hung Mien-Chie , Chen Junjie
Published: April 2023

ProPTPRN2, mature PTPRN2, or proPTPRN2 (DPTP)-associated proteins identified by mass spectrometry analysis in stable MDA-MB-468 cells.
Supplementary Figures 1-6 from Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis
Authors: Sorokin Alexey V. , Nair Binoj C. , Wei Yongkun , Aziz Kathryn E. , Evdokimova Valentina , Hung Mien-Chie , Chen Junjie
Published: April 2023

Supplementary Figures 1-6 Supplementary Figure 1. PTPRN2 expression in normal and cancer tissues. Supplementary Figure 2. Validation of PTPRN2 antibodies for immunohistochemistry (IHC) and Western blot (WB) analysis. Supplementary Figure 3. MCF10A cells expressing proPTPRN2 forms larger acinar structures in Matrigel. Supplementary Figure 4. PTPRN2 is involved in IϰB/NF-ϰB and c-Jun N-terminal kinase (JNK)/AP-1 signaling pathways. Supplementary Figure 5. PTPRN2 knockdown induces apoptosis in MDA-MB-468 cells. Supplementary Figure 6. Overexpression of proPTPRN2 but not mature PTPRN2 suppresses TRAF2 phosphorylation.
Supplemental Table S1 from Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network
Authors: Zhu Jieqing , Xiong Gaofeng , Fu Hanjiang , Evers B. Mark , Zhou Binhua P. , Xu Ren
Published: April 2023

Supplemental Table S1. Expression of Hsp47 and ECM protein genes is correlated in mammary cell lines.
Table S5. DAVID functional classification of ixazomib genes. from Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma
Authors: Ravi Dashnamoorthy , Beheshti Afshin , Abermil Nasséra , Passero Frank , Sharma Jaya , Coyle Michael , Kritharis Athena , Kandela Irawati , Hlatky Lynn , Sitkovsky Michail V. , Mazar Andrew , Gartenhaus Ronald B. , Evens Andrew M.
Published: April 2023

Functional annotation clusters determined from the common genes in ixazomib 25nM/24 hours vs. Control for Jurkat, L540, and L428 cells (Fig. 1C). This was determined through DAVID Gene Functional Classification Tool. The enrichment scores were determined by DAVID through the geometric mean of the EASE scores (modified Fisher Exact).
Table S1. Common upstream regulators. from Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma
Authors: Ravi Dashnamoorthy , Beheshti Afshin , Abermil Nasséra , Passero Frank , Sharma Jaya , Coyle Michael , Kritharis Athena , Kandela Irawati , Hlatky Lynn , Sitkovsky Michail V. , Mazar Andrew , Gartenhaus Ronald B. , Evens Andrew M.
Published: April 2023

A. Common upstream regulators predicted to be activated or inhibited (as indicated by the activation Z-score) in the ixazomib 25nM/24 hours versus control for Jurkat, L540 and L428 cells obtained through the use of Ingenuity Pathway Analysis (IPA) software. Regulation z-score indicates the degree of inhibition (for negative values) or activation (for positive values). The third column denotes the effects that the upstream regulators have on tumor progression (reference in parenthesis). B. Common upstream regulators predicted to be activated or inhibited (as described in Table S1A), are highlighted (shaded in red) based on their functional link in "hallmarks of cancer," with literature evidences listed.
Supplementary Table S4 from Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway
Authors: Crowther Andrew J. , Ocasio Jennifer K. , Fang Fang , Meidinger Jessica , Wu Jaclyn , Deal Allison M. , Chang Sha X. , Yuan Hong , Schmid Ralf , Davis Ian , Gershon Timothy R.
Published: April 2023

Control geneses used for transcriptomic analysis.
Supplementary Table S3 from Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway
Authors: Crowther Andrew J. , Ocasio Jennifer K. , Fang Fang , Meidinger Jessica , Wu Jaclyn , Deal Allison M. , Chang Sha X. , Yuan Hong , Schmid Ralf , Davis Ian , Gershon Timothy R.
Published: April 2023

List of significantly up-regulated gene sets.
Supplementary Figure Legends from Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity
Authors: Shanker Anil , Pellom Samuel T. , Dudimah Duafalia F. , Thounaojam Menaka C. , de Kluyver Rachel L. , Brooks Alan D. , Yagita Hideo , McVicar Daniel W. , Murphy William J. , Longo Dan L. , Sayers Thomas J.
Published: April 2023

Legends for Supplementary Figures S1-S3.
Supplemental Figures and Tables from Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance
Authors: AlHossiny Midrar , Luo Linlin , Frazier William R. , Steiner Noriko , Gusev Yuriy , Kallakury Bhaskar , Glasgow Eric , Creswell Karen , Madhavan Subha , Kumar Rakesh , Upadhyay Geeta
Published: April 2023

Table S1: List of qRT-PCR primers; Table. S2: Summary table of mRNA expression for Ly6K and Ly6E in normal and cancer samples in seven comparison; Fig. S1. Expression of Ly6K and Ly6E in human normal and breast cancer tissues; Fig. S2: The knockdown for Ly6K and Ly6E is specific; Fig. S3: Colony assay; Fig. S4: The Ly6K gene is required for intravasation, extravasation and colonization of cancer cells; Fig. S5: Comparison of CD274, CTLA4, IL2RA, LY6E and LY6K gene expression in clinical samples of breast cancer in indicated 6 analysis in three different datasets; Fig. S6: High expression of Ly6K and Ly6E impair NK cell binding to cancer cell; Fig. S7: Indicated cells (MDA-MB-231) were treated with 100ng/ml IFN-g overnight; Fig. S8: Rescue over expression phenotype.
Supplemental Figure S4 from Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
Authors: Wallerius Majken , Wallmann Tatjana , Bartish Margarita , Östling Jeanette , Mezheyeuski Artur , Tobin Nicholas P. , Nygren Emma , Pangigadde Pradeepa , Pellegrini Paola , Squadrito Mario Leonardo , Pontén Fredrik , Hartman Johan , Bergh Jonas , De Milito Angelo , De Palma Michele , Östman Arne , Andersson John , Rolny Charlotte
Published: April 2023

MACROPHAGE DEPLETION BY ANTI-CSF1.
Supplementary Figure S4 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: April 2023

Survival of patients included in the Belob trial stratified by molecular subtype.
Supplemental Figure S3 from Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
Authors: Wallerius Majken , Wallmann Tatjana , Bartish Margarita , Östling Jeanette , Mezheyeuski Artur , Tobin Nicholas P. , Nygren Emma , Pangigadde Pradeepa , Pellegrini Paola , Squadrito Mario Leonardo , Pontén Fredrik , Hartman Johan , Bergh Jonas , De Milito Angelo , De Palma Michele , Östman Arne , Andersson John , Rolny Charlotte
Published: April 2023

INCREASED ACCUMULATION OF LYMPHOCYTES IN SEMA3A TUMORS.
Supplementary Figure S3 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: April 2023

Correlation between DASL beadchips and RNA-seq on two individual Belob trial samples.
Supplemental Figure Legends from Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages
Authors: Wallerius Majken , Wallmann Tatjana , Bartish Margarita , Östling Jeanette , Mezheyeuski Artur , Tobin Nicholas P. , Nygren Emma , Pangigadde Pradeepa , Pellegrini Paola , Squadrito Mario Leonardo , Pontén Fredrik , Hartman Johan , Bergh Jonas , De Milito Angelo , De Palma Michele , Östman Arne , Andersson John , Rolny Charlotte
Published: April 2023

Legend for Supplemental Figures S1-S6.
Supplementary Figure S12 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: April 2023

Correlation between the 5' - 3' pre-mRNA slope and the level of expression of the mature (spliced) transcript.
Supplementary Figure S3 from Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants In Vivo with Magnetic Resonance Elastography
Authors: Jamin Yann , Boult Jessica K.R. , Li Jin , Popov Sergey , Garteiser Philippe , Ulloa Jose L. , Cummings Craig , Box Gary , Eccles Suzanne A. , Jones Chris , Waterton John C. , Bamber Jeffrey C. , Sinkus Ralph , Robinson Simon P.
Published: April 2023

Supplementary Figure S3. Representative Luxol Fast Blue staining for myelin fibres within intracranial U-87 MG, RG2 and MDA-MB-231 tumors.
Supplementary Figure Legends from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial
Authors: Erdem-Eraslan Lale , van den Bent Martin J. , Hoogstrate Youri , Naz-Khan Hina , Stubbs Andrew , van der Spek Peter , Böttcher René , Gao Ya , de Wit Maurice , Taal Walter , Oosterkamp Hendrika M. , Walenkamp Annemiek , Beerepoot Laurens V. , Hanse Monique C.J. , Buter Jan , Honkoop Aafke H. , van der Holt Bronno , Vernhout René M. , Smitt Peter A.E. Sillevis , Kros Johan M. , French Pim J.
Published: April 2023

Legends for Supplementary Figures S1-S13.
Supplementary Figure S7 from Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis
Authors: Lin Jieru E. , Colon-Gonzalez Francheska , Blomain Erik , Kim Gilbert W. , Aing Amanda , Stoecker Brian , Rock Justin , Snook Adam E. , Zhan Tingting , Hyslop Terry M. , Tomczak Michal , Blumberg Richard S. , Waldman Scott A.
Published: April 2023

Body weights and guanylin expression in C57BL/6 mice on a lean or high fat (HF) diet, or switched from a high fat to a lean diet (HF-Lean).
Supplementary Figure S5 from Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis
Authors: Lin Jieru E. , Colon-Gonzalez Francheska , Blomain Erik , Kim Gilbert W. , Aing Amanda , Stoecker Brian , Rock Justin , Snook Adam E. , Zhan Tingting , Hyslop Terry M. , Tomczak Michal , Blumberg Richard S. , Waldman Scott A.
Published: April 2023

Daily calorie intake, body weights, and guanylin expression in Balb/c mice on lean or high fat (HF) diets.
Supplementary Figure S1 from Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity
Authors: Zhao Weina , Prijic Sara , Urban Bettina C. , Tisza Michael J. , Zuo Yan , Li Lin , Tan Zhi , Chen Xiaoling , Mani Sendurai A. , Chang Jeffrey T.
Published: April 2023

Embryonic EMT signature.
Supplementary Table S1 from Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression
Authors: Picon-Ruiz Manuel , Pan Chendong , Drews-Elger Katherine , Jang Kibeom , Besser Alexandra H. , Zhao Dekuang , Morata-Tarifa Cynthia , Kim Minsoon , Ince Tan A. , Azzam Diana J. , Wander Seth A. , Wang Bin , Ergonul Burcu , Datar Ram H. , Cote Richard J. , Howard Guy A. , El-Ashry Dorraya , Torné-Poyatos Pablo , Marchal Juan A. , Slingerland Joyce M.
Published: April 2023

Primer Sequences.
Supplementary Table S1 from H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis
Authors: Park Woo-Yong , Hong Beom-Jin , Lee Jungsul , Choi Chulhee , Kim Mi-Young
Published: April 2023

JMJD3 promotes melanoma initiation.
Supplementary Figure S1 from H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis
Authors: Park Woo-Yong , Hong Beom-Jin , Lee Jungsul , Choi Chulhee , Kim Mi-Young
Published: April 2023

Characterization of JMJD3-overexpressing and knockout melanoma cell lines.
Supplementary Figure S1 from CRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α
Authors: Tian Xi , Nguyen Minh , Foote Henry P. , Caster Joseph M. , Roche Kyle C. , Peters Christian G. , Wu Pauline , Jayaraman Lata , Garmey Edward G. , Tepper Joel E. , Eliasof Scott , Wang Andrew Z.
Published: April 2023

There is a linear relationship between the number of HT-29-Luc2 cells and the luminescence intensity.
Supplemental Figure Legends from EF Hand Protein IBA2 Promotes Cell Proliferation in Breast Cancers via Transcriptional Control of Cyclin D1
Authors: Zhang Ying , Wang Shuling , Li Lingsong
Published: April 2023

Supplemental Figure Legends
Supplemental Figure Legends from SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation
Authors: Bilir Birdal , Osunkoya Adeboye O. , Wiles W. Guy , Sannigrahi Soma , Lefebvre Veronique , Metzger Daniel , Spyropoulos Demetri D. , Martin W. David , Moreno Carlos S.
Published: April 2023

Supplemental Figure Legends
Figure S9 from Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas
Authors: Droog Marjolein , Nevedomskaya Ekaterina , Kim Yongsoo , Severson Tesa , Flach Koen D. , Opdam Mark , Schuurman Karianne , Gradowska Patrycja , Hauptmann Michael , Dackus Gwen , Hollema Harry , Mourits Marian J. , Nederlof Petra , van Boven Hester , Linn Sabine C. , Wessels Lodewyk , van Leeuwen Flora E. , Zwart Wilbert
Published: April 2023

Box plot, depicting interval time (years) between breast cancer diagnosis and endometrial cancer diagnosis and endometrial cancer diagnosis for patients who did not receive tamoxifen.
Supplementary Figure Legends from Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre–metastatic Niche
Authors: Giles Amber Jin , Reid Caitlin Marie , Evans Justin DeWayne , Murgai Meera , Vicioso Yorleny , Highfill Steven Lorenz , Kasai Miki , Vahdat Linda , Mackall Crystal Lee , Lyden David , Wexler Leonard , Kaplan Rosandra Natasha
Published: April 2023

Legends for Supplementary Figures 1-6.
Supplementary Materials and Methods from Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis
Authors: Nakajima Kosei , Kho Dhong Hyo , Yanagawa Takashi , Harazono Yosuke , Hogan Victor , Chen Wei , Ali-Fehmi Rouba , Mehra Rohit , Raz Avraham
Published: April 2023

Materials and Methods for Tissue microarray, Immunofluorescence, Quantitative Real-Time PCR, Proteomics analysis, Co-immunoprecipitation, Co-culture.
Supplementary Figure S3 from Macrophage Infiltration and Alternative Activation during Wound Healing Promote MEK1-Induced Skin Carcinogenesis
Authors: Weber Christine , Telerman Stephanie B. , Reimer Andreas S. , Sequeira Ines , Liakath-Ali Kifayathullah , Arwert Esther N. , Watt Fiona M.
Published: April 2023

Gene expression profiling of dermal wound macrophages & monocytes
Supplementary Figure S4 from Comprehensive Ex Vivo Transposon Mutagenesis Identifies Genes That Promote Growth Factor Independence and Leukemogenesis
Authors: Guo Yabin , Updegraff Barrett L. , Park Sunho , Durakoglugil Deniz , Cruz Victoria H. , Maddux Sarah , Hwang Tae Hyun , O'Donnell Kathryn A.
Published: April 2023

Consensus clustering analysis of the top 163 CIS genes in acute lymphocytic leukemia.
Supplementary Figure Legend from Macrophage Infiltration and Alternative Activation during Wound Healing Promote MEK1-Induced Skin Carcinogenesis
Authors: Weber Christine , Telerman Stephanie B. , Reimer Andreas S. , Sequeira Ines , Liakath-Ali Kifayathullah , Arwert Esther N. , Watt Fiona M.
Published: April 2023

Legend for Supplementary Figures S1-S6.
Supplementary Table 1 from Antagonizing Integrin β3 Increases Immunosuppression in Cancer
Authors: Su Xinming , Esser Alison K. , Amend Sarah R. , Xiang Jingyu , Xu Yalin , Ross Michael H. , Fox Gregory C. , Kobayashi Takayuki , Steri Veronica , Roomp Kirsten , Fontana Francesca , Hurchla Michelle A. , Knolhoff Brett L. , Meyer Melissa A. , Morgan Elizabeth A. , Tomasson Julia C. , Novack Joshua S. , Zou Wei , Faccio Roberta , Novack Deborah V. , Robinson Stephen D. , Teitelbaum Steven L. , DeNardo David G. , Schneider Jochen G. , Weilbaecher Katherine N.
Published: April 2023

The percentage of infiltrating immune cells in B16 tumor tissue
Supplementary Figure 9 from Antagonizing Integrin β3 Increases Immunosuppression in Cancer
Authors: Su Xinming , Esser Alison K. , Amend Sarah R. , Xiang Jingyu , Xu Yalin , Ross Michael H. , Fox Gregory C. , Kobayashi Takayuki , Steri Veronica , Roomp Kirsten , Fontana Francesca , Hurchla Michelle A. , Knolhoff Brett L. , Meyer Melissa A. , Morgan Elizabeth A. , Tomasson Julia C. , Novack Joshua S. , Zou Wei , Faccio Roberta , Novack Deborah V. , Robinson Stephen D. , Teitelbaum Steven L. , DeNardo David G. , Schneider Jochen G. , Weilbaecher Katherine N.
Published: April 2023

Integrin beta3 antagonist treatment on tumor cells and BMMs in culture
Supplementary Table S3 from MSH2 Dysregulation Is Triggered by Proinflammatory Cytokine Stimulation and Is Associated with Liver Cancer Development
Authors: Eso Yuji , Takai Atsushi , Matsumoto Tomonori , Inuzuka Tadashi , Horie Takahiro , Ono Koh , Uemoto Shinji , Lee Kyeryoung , Edelmann Winfried , Chiba Tsutomu , Marusawa Hiroyuki
Published: April 2023

Summary of somatic mutations in HCC tissues of each mouse type detected by whole-exome sequencing
Supplementary Table S2 from MSH2 Dysregulation Is Triggered by Proinflammatory Cytokine Stimulation and Is Associated with Liver Cancer Development
Authors: Eso Yuji , Takai Atsushi , Matsumoto Tomonori , Inuzuka Tadashi , Horie Takahiro , Ono Koh , Uemoto Shinji , Lee Kyeryoung , Edelmann Winfried , Chiba Tsutomu , Marusawa Hiroyuki
Published: April 2023

Summary of whole-exome sequencing
Supplementary Figure S2 from MSH2 Dysregulation Is Triggered by Proinflammatory Cytokine Stimulation and Is Associated with Liver Cancer Development
Authors: Eso Yuji , Takai Atsushi , Matsumoto Tomonori , Inuzuka Tadashi , Horie Takahiro , Ono Koh , Uemoto Shinji , Lee Kyeryoung , Edelmann Winfried , Chiba Tsutomu , Marusawa Hiroyuki
Published: April 2023

In silico identification of miR-21 and the effect of miR-21 decoy gene.
Supplementary Figure 1 from Antagonizing Integrin β3 Increases Immunosuppression in Cancer
Authors: Su Xinming , Esser Alison K. , Amend Sarah R. , Xiang Jingyu , Xu Yalin , Ross Michael H. , Fox Gregory C. , Kobayashi Takayuki , Steri Veronica , Roomp Kirsten , Fontana Francesca , Hurchla Michelle A. , Knolhoff Brett L. , Meyer Melissa A. , Morgan Elizabeth A. , Tomasson Julia C. , Novack Joshua S. , Zou Wei , Faccio Roberta , Novack Deborah V. , Robinson Stephen D. , Teitelbaum Steven L. , DeNardo David G. , Schneider Jochen G. , Weilbaecher Katherine N.
Published: April 2023

Blood vessel density analysis of tumor tissue
Supplementary Tables S1-S3 from TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment
Authors: Boutet Marie , Gauthier Ludiane , Leclerc Marine , Gros Gwendoline , de Montpreville Vincent , Théret Nathalie , Donnadieu Emmanuel , Mami-Chouaib Fathia
Published: April 2023

Statistical analyses of results shown in Figure 1A (S1); Statistical analyses of results shown in Supplementary Figure 1A (S2); Statistical analyses of results shown in Supplementary Figure 2B (S3).
Supplementary Figures 1 through 6 from Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB–IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells
Authors: Saha Shilpi , Mukherjee Shravanti , Khan Poulami , Kajal Kirti , Mazumdar Minakshi , Manna Argha , Mukherjee Sanhita , De Sunanda , Jana Debarshi , Sarkar Diptendra K. , Das Tanya
Published: April 2023

Supplementary Figure S1: Immunohistological images representing ER, PR and Her2 staining of primary tumor cells and schematic representation showing flow cytometric sorting. Supplementary Figure S2: FAC-based chemotherapy increases CSC pool in different breast cancer cells. Supplementary Figure S3: FAC-based chemotherapy generates aggressive CSC pool. Supplementary Figure S4: Therapy fails to induce CSC-markers in purified NSCCs of MCF-7 cells. Supplementary Figure S5: Therapy induces translocation of NFÃŽÂºB in nucleus of CSCs. Supplementary Figure S6: Aspirin treatment perturbs NFÃŽÂºB nuclear translocation in CSC-enriched spheres and chemo-sensitizes CSCs to genotoxic therapy.
Supplementary Experimental Procedures from Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB–IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells
Authors: Saha Shilpi , Mukherjee Shravanti , Khan Poulami , Kajal Kirti , Mazumdar Minakshi , Manna Argha , Mukherjee Sanhita , De Sunanda , Jana Debarshi , Sarkar Diptendra K. , Das Tanya
Published: April 2023

Detail description of determination of response to neo-adjuvant chemotherapy, Western blotting, RT-PCR Assay, ELISA, chromatin immunoprecipitation assay and immunohistochemistry